Kevin Dzobo

4.7k total citations · 2 hit papers
53 papers, 3.2k citations indexed

About

Kevin Dzobo is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kevin Dzobo has authored 53 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Kevin Dzobo's work include Cancer Cells and Metastasis (14 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Kevin Dzobo is often cited by papers focused on Cancer Cells and Metastasis (14 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Kevin Dzobo collaborates with scholars based in South Africa, Ghana and United States. Kevin Dzobo's co-authors include Nicholas Ekow Thomford, Collet Dandara, Dimakatso Alice Senthebane, Arielle Rowe, Alfred Maroyi, Palesa Pamela Seele, M. Iqbal Parker, Keolebogile Shirley Motaung, Ambroise Wonkam and Adetola B. Adesida and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Kevin Dzobo

53 papers receiving 3.1k citations

Hit Papers

Natural Products for Drug Discovery in the 21st Century: ... 2018 2026 2020 2023 2018 2023 250 500 750

Peers

Kevin Dzobo
Kevin Dzobo
Citations per year, relative to Kevin Dzobo Kevin Dzobo (= 1×) peers Nicholas Ekow Thomford

Countries citing papers authored by Kevin Dzobo

Since Specialization
Citations

This map shows the geographic impact of Kevin Dzobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Dzobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Dzobo more than expected).

Fields of papers citing papers by Kevin Dzobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Dzobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Dzobo. The network helps show where Kevin Dzobo may publish in the future.

Co-authorship network of co-authors of Kevin Dzobo

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Dzobo. A scholar is included among the top collaborators of Kevin Dzobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Dzobo. Kevin Dzobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dzobo, Kevin, Dimakatso Alice Senthebane, & Collet Dandara. (2023). The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited. Cancers. 15(2). 376–376. 90 indexed citations breakdown →
3.
Özdemir, Vural, Simon Springer, Semra Şardaş, et al.. (2021). Thanatechnology and the Living Dead: New Concepts in Digital Transformation and Human-Computer Interaction. Australasian Journal of Paramedicine. 25(7). 401–407. 7 indexed citations
4.
Dzobo, Kevin & Musalula Sinkala. (2021). Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis. OMICS A Journal of Integrative Biology. 25(5). 313–332. 41 indexed citations
5.
Dzobo, Kevin, et al.. (2020). Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development. OMICS A Journal of Integrative Biology. 25(2). 81–92. 19 indexed citations
6.
Dzobo, Kevin, et al.. (2020). Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine. OMICS A Journal of Integrative Biology. 25(1). 13–22. 16 indexed citations
7.
Dzobo, Kevin. (2020). Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic. OMICS A Journal of Integrative Biology. 24(4). 175–179. 46 indexed citations
8.
Dzobo, Kevin, et al.. (2019). Interleukin-6 Induces Myogenic Differentiation via JAK2-STAT3 Signaling in Mouse C2C12 Myoblast Cell Line and Primary Human Myoblasts. International Journal of Molecular Sciences. 20(21). 5273–5273. 67 indexed citations
9.
Thomford, Nicholas Ekow, Christian Domilongo Bope, Francis E. Agamah, et al.. (2019). Implementing Artificial Intelligence and Digital Health in Resource-Limited Settings? Top 10 Lessons We Learned in Congenital Heart Defects and Cardiology. OMICS A Journal of Integrative Biology. 24(5). 264–277. 27 indexed citations
10.
Dzobo, Kevin, Nicholas Ekow Thomford, Dimakatso Alice Senthebane, et al.. (2018). Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine. Stem Cells International. 2018. 1–24. 286 indexed citations
11.
Dzobo, Kevin, et al.. (2018). Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling. OMICS A Journal of Integrative Biology. 22(12). 733–748. 23 indexed citations
12.
Dzobo, Kevin, et al.. (2017). The Future of Tissue Engineering and Regenerative Medicine in Africa. Tissue Engineering Part A. 23(19-20). 1023–1025. 3 indexed citations
13.
14.
Matimba, Alice, et al.. (2017). Disease burden and the role of pharmacogenomics in African populations. PubMed. 2. e1–e1. 26 indexed citations
15.
Dzobo, Kevin, Arielle Rowe, Karlien Kallmeyer, et al.. (2016). Fibroblast-Derived Extracellular Matrix Induces Chondrogenic Differentiation in Human Adipose-Derived Mesenchymal Stromal/Stem Cells in Vitro. International Journal of Molecular Sciences. 17(8). 1259–1259. 42 indexed citations
16.
Dzobo, Kevin, Matjaž Vogelsang, Nicholas Ekow Thomford, et al.. (2016). Wharton’s Jelly‐Derived Mesenchymal Stromal Cells and Fibroblast‐Derived Extracellular Matrix Synergistically Activate Apoptosis in a p21‐Dependent Mechanism in WHCO1 and MDA MB 231 Cancer Cells In Vitro. Stem Cells International. 2016(1). 4842134–4842134. 27 indexed citations
17.
Kaschula, Catherine H., Roger Hunter, Jonathan Cotton, et al.. (2015). The garlic compound ajoene targets protein folding in the endoplasmic reticulum of cancer cells. Molecular Carcinogenesis. 55(8). 1213–1228. 37 indexed citations
18.
Dzobo, Kevin, Matjaž Vogelsang, & M. Iqbal Parker. (2015). Wnt/β-Catenin and MEK-ERK Signaling are Required for Fibroblast-Derived Extracellular Matrix-Mediated Endoderm Differentiation of Embryonic Stem Cells. Stem Cell Reviews and Reports. 11(5). 761–773. 22 indexed citations
19.
Vogelsang, Matjaž, Juliano D. Paccez, Georgia Schäfer, et al.. (2014). Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke. Journal of Cancer Research and Clinical Oncology. 140(11). 1825–1833. 20 indexed citations
20.
Dzobo, Kevin, Virna D. Leaner, & M. Iqbal Parker. (2014). Absence of feedback regulation in the synthesis of COL1A1. Life Sciences. 103(1). 25–33. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026